Turning Point Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: TPTX insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 65.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.3%	The Vanguard Group, Inc.	4,157,552	US$316.0m	6.25%	0.01%
7.57%	BlackRock, Inc.	3,791,801	US$288.2m	2.7%	0.01%
4.96%	Cormorant Asset Management, LP	2,484,220	US$188.8m	-32.9%	10.74%
4.5%	SR One Capital Management, LP	2,253,660	US$171.3m	0%	27.72%
4.02%	OrbiMed Advisors LLC	2,012,250	US$153.0m	-0.33%	2.3%
3.81%	Wellington Management Group LLP	1,910,170	US$145.2m	-52.6%	0.02%
3.3%	State Street Global Advisors, Inc.	1,650,689	US$125.5m	-47.1%	0.01%
3.2%	Jingrong Cui	1,604,681	US$122.0m	0%	no data
2.32%	Fidelity International Ltd	1,163,475	US$88.4m	0%	0.04%
2.05%	Alpine Associates Advisors	1,028,400	US$78.2m	0%	3.53%
1.91%	T. Rowe Price Group, Inc.	953,914	US$72.5m	-75.9%	0.01%
1.84%	Magnetar Capital, LLC	923,581	US$70.2m	0%	0.87%
1.83%	Federated Hermes, Inc.	918,500	US$69.8m	-55.7%	0.18%
1.75%	HBM Partners Ltd.	877,159	US$66.7m	164%	5.14%
1.74%	Geode Capital Management, LLC	871,686	US$66.3m	-4.56%	0.01%
1.64%	Soros Fund Management LLC	821,635	US$62.5m	0%	1.38%
1.36%	FMR LLC	680,887	US$51.8m	-10.6%	no data
1.25%	Versor Investments LP	625,067	US$47.5m	0%	1.88%
1.22%	Millennium Management LLC	610,489	US$46.4m	405%	0.05%
1.2%	Highland Capital Management, L.P.	602,108	US$45.8m	0%	5.09%
1.2%	Glazer Capital, LLC	600,368	US$45.6m	0%	1.1%
1.14%	Tavistock Life Sciences	570,745	US$43.4m	42.7%	1.85%
1.13%	Spring Creek Capital, LLC	566,315	US$43.0m	0%	1.89%
1.13%	Pentwater Capital Management LP	564,714	US$42.9m	0%	0.76%
1.09%	American Century Investment Management Inc	547,354	US$41.6m	0%	0.03%